These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37857434)

  • 1. Dexamethasone for preterm infants at risk of bronchopulmonary dysplasia: is timing everything?
    Been JV; Simons SHP; Labrecque JA
    Eur Respir J; 2023 Oct; 62(4):. PubMed ID: 37857434
    [No Abstract]   [Full Text] [Related]  

  • 2. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.
    Dani C; Bertini G; Simone P; Rubaltelli FF
    Pediatrics; 2006 May; 117(5):1866-7. PubMed ID: 16651362
    [No Abstract]   [Full Text] [Related]  

  • 4. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postnatal glucocorticoids in very preterm infants: "the good, the bad, and the ugly"?
    Thébaud B; Lacaze-Masmonteil T; Watterberg K
    Pediatrics; 2001 Feb; 107(2):413-5. PubMed ID: 11158479
    [No Abstract]   [Full Text] [Related]  

  • 6. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
    Watterberg KL;
    Pediatrics; 2010 Oct; 126(4):800-8. PubMed ID: 20819899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of postnatal dexamethasone timing on preterm mortality and bronchopulmonary dysplasia: a propensity score analysis.
    Kwok TC; Szatkowski L; Sharkey D
    Eur Respir J; 2023 Oct; 62(4):. PubMed ID: 37591537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
    Williams AF
    Arch Dis Child; 1993 Sep; 69(3 Spec No):331. PubMed ID: 8215580
    [No Abstract]   [Full Text] [Related]  

  • 9. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
    Ng PC
    Arch Dis Child; 1993 Mar; 68(3 Spec No):330-6. PubMed ID: 8466274
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucocorticoids in preterm infants and discrepancies of vascular endothelial growth factor.
    Vento G; Matassa PG; Capoluongo E; Tortorolo L; Romagnoli C; Ameglio F; Lassus P; Andersson S
    Am J Respir Crit Care Med; 2003 Aug; 168(4):501; author reply 501-2. PubMed ID: 12912737
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical study on plasma biomarkers for deciding the use of adjuvant corticosteroid therapy in bronchopulmonary dysplasia of premature infants.
    Zhu H; Tian Y; Cheng H; Zheng Y; Wang W; Bao T; Wu R; Tian Z
    Int J Med Sci; 2021; 18(12):2581-2588. PubMed ID: 34104089
    [No Abstract]   [Full Text] [Related]  

  • 12. Postnatal corticosteroids for preterm infants--do what we say, not what we do.
    Jobe AH
    N Engl J Med; 2004 Mar; 350(13):1349-51. PubMed ID: 15044647
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed Dexamethasone Therapy and Neurodevelopmental Outcomes in Preterm Infants with Bronchopulmonary Dysplasia.
    Lim G; Lee BS; Choi YS; Park HW; Chung ML; Choi HJ; Kim EA; Kim KS
    Pediatr Neonatol; 2015 Aug; 56(4):261-7. PubMed ID: 25649722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies.
    Papagianis PC; Pillow JJ; Moss TJ
    Paediatr Respir Rev; 2019 Apr; 30():34-41. PubMed ID: 30201135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Neonatology; 2010; 98(3):217-24. PubMed ID: 20389126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dexamethasone treatment on serum GH, IGF-I, and the binding proteins IGFBP-1 and -3 in ventilated very preterm infants.
    Huysman MW; Hokken-Koelega AC; Hop WC; Sauer PJ
    Pediatr Res; 2003 Jul; 54(1):37-43. PubMed ID: 12646720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
    Onland W; De Jaegere AP; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010941. PubMed ID: 28141913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone therapy in preterm infants developing bronchopulmonary dysplasia: effect on pulmonary surfactant disaturated-phosphatidylcholine kinetics.
    Cogo PE; Simonato M; Mariatoffolo G; Stefanutti G; Chierici M; Cobelli C; Ori C; Carnielli VP
    Pediatr Res; 2008 Apr; 63(4):433-7. PubMed ID: 18356753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia.
    Kari MA; Heinonen K; Ikonen RS; Koivisto M; Raivio KO
    Arch Dis Child; 1993 May; 68(5 Spec No):566-9. PubMed ID: 8323356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using dexamethasone wisely in invasively ventilated preterm infants.
    Gentle SJ; Sant'Anna G; Carlo WA
    Pediatr Pulmonol; 2022 Apr; 57(4):785-786. PubMed ID: 34994096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.